Roche Holding (SWX:ROP) and its subsidiary Genentech are presenting new breast cancer data at the ASCO 2026 Annual Meeting.
Chief Executive Officer Yuval Cohen said investors should expect more mature clinical updates for CRB-701 at the upcoming ...
Arcus Biosciences is preparing for a readout at the ASCO Annual Meeting, which could be a significant catalyst for the company. The company has a strong financial position with $1.1 billion in current ...
An update from BioNTech SE ( (BNTX) ) is now available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results